Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 07 05 2019
accepted: 30 07 2019
entrez: 24 8 2019
pubmed: 24 8 2019
medline: 30 9 2020
Statut: epublish

Résumé

The complement system is crucial for defense against pathogens and the removal of dying cells or immune complexes. Thus, clinical indications for possible complete complement deficiencies include, among others, recurrent mild or serious bacterial infections as well as autoimmune diseases (AID). The diagnostic approach includes functional activity measurements of the classical (CH50) and alternative pathway (AP50) and the determination of the C3 and C4 levels, followed by the quantitative analysis of individual components or regulators. When biochemical analysis reveals the causal abnormality of the complement deficiency (CD), molecular mechanisms remains frequently undetermined. Here, using direct sequencing analysis of the coding region we report the pathogenic variants spectrum that underlie the total or subtotal complement deficiency in 212 patients. We identified 107 different hemizygous, homozygous, or compound heterozygous pathogenic variants in 14 complement genes [

Identifiants

pubmed: 31440263
doi: 10.3389/fimmu.2019.01936
pmc: PMC6694794
doi:

Substances chimiques

Complement System Proteins 9007-36-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1936

Références

Mol Immunol. 1999 Sep-Oct;36(13-14):863-7
pubmed: 10698340
Eur J Hum Genet. 2000 Jul;8(7):513-8
pubmed: 10909851
Am J Med Genet. 2001 Apr 1;99(4):325-7
pubmed: 11252001
J Immunol. 2001 Jun 15;166(12):7612-6
pubmed: 11390518
J Clin Invest. 2001 Jul;108(2):233-40
pubmed: 11457876
Clin Exp Immunol. 2003 Apr;132(1):87-91
pubmed: 12653841
J Exp Med. 2004 May 17;199(10):1295-9
pubmed: 15148331
J Med Genet. 2004 Jun;41(6):e84
pubmed: 15173250
Medicine (Baltimore). 2005 Jan;84(1):23-34
pubmed: 15643297
J Biol Chem. 1992 May 5;267(13):9347-53
pubmed: 1577763
Blood. 2006 Jun 15;107(12):4865-70
pubmed: 16527897
Hum Mol Genet. 2006 Sep 1;15(17):2650-8
pubmed: 16885193
Eur J Immunol. 2007 May;37(5):1377-85
pubmed: 17407100
Mol Immunol. 2008 Jan;45(1):95-105
pubmed: 17597211
Clin Microbiol Rev. 1991 Jul;4(3):359-95
pubmed: 1889047
Kidney Int. 2010 Feb;77(4):339-49
pubmed: 20016463
Nat Immunol. 2010 Sep;11(9):785-97
pubmed: 20720586
J Immunol Methods. 2011 Feb 28;365(1-2):8-26
pubmed: 21215749
J Immunol. 2011 Oct 15;187(8):4369-73
pubmed: 21930969
Scand J Immunol. 2012 Apr;75(4):445-8
pubmed: 22229731
Clin Exp Immunol. 2012 Mar;167(3):459-71
pubmed: 22288589
Gene. 2013 May 25;521(1):204-6
pubmed: 23537992
Virulence. 2014 Jan 1;5(1):98-126
pubmed: 24104403
J Clin Immunol. 2013 Nov;33(8):1293-301
pubmed: 24142231
N Engl J Med. 2013 Oct 24;369(17):1667-9
pubmed: 24152280
Mol Immunol. 2014 Apr;58(2):201-5
pubmed: 24378253
Clin Infect Dis. 2014 Jul 15;59(2):244-51
pubmed: 24759830
Mol Immunol. 2014 Oct;61(2):110-7
pubmed: 25037634
Mol Immunol. 2015 Mar;64(1):170-6
pubmed: 25534848
Hum Mol Genet. 2015 Jul 1;24(13):3861-70
pubmed: 25788521
Front Immunol. 2015 May 26;6:257
pubmed: 26074922
Front Immunol. 2015 Jun 02;6:262
pubmed: 26082779
J Clin Invest. 1989 Dec;84(6):1957-61
pubmed: 2687330
Front Immunol. 2016 Feb 24;7:55
pubmed: 26941740
J Clin Immunol. 2016 May;36(4):388-96
pubmed: 27026170
Nat Rev Nephrol. 2016 Jul;12(7):383-401
pubmed: 27211870
Immunol Rev. 2016 Nov;274(1):152-171
pubmed: 27782321
Immunol Rev. 2016 Nov;274(1):74-97
pubmed: 27782323
EMBO J. 2017 Apr 13;36(8):1084-1099
pubmed: 28264884
J Infect. 2017 Jun;74(6):564-574
pubmed: 28279715
J Infect Dis. 2017 Apr 15;215(8):1331-1338
pubmed: 28368462
Clin Exp Immunol. 2017 Aug;189(2):226-231
pubmed: 28369827
Mol Immunol. 2017 Sep;89:10-21
pubmed: 28576323
Kidney Int. 2018 Feb;93(2):470-481
pubmed: 28941939
Nat Rev Nephrol. 2018 Jan;14(1):26-47
pubmed: 29199277
J Allergy Clin Immunol. 2018 Jul;142(1):311-314.e6
pubmed: 29522842
Front Immunol. 2018 Oct 24;9:2237
pubmed: 30405598
EMBO J. 2019 Feb 15;38(4):null
pubmed: 30643019
Int Rev Immunol. 1993;10(1):51-64
pubmed: 8340677
J Biol Chem. 1997 Oct 3;272(40):25168-75
pubmed: 9312129
Immunopharmacology. 1997 Dec;38(1-2):203-6
pubmed: 9476131
Hum Genet. 1998 Oct;103(4):506-12
pubmed: 9856498

Auteurs

Carine El Sissy (C)

Assistance Publique - Hôpitaux de Paris (AP-HP), Laboratoire d'Immunologie, Hôpital Européen Georges-Pompidou, Paris, France.

Jérémie Rosain (J)

Assistance Publique - Hôpitaux de Paris (AP-HP), Laboratoire d'Immunologie, Hôpital Européen Georges-Pompidou, Paris, France.

Paula Vieira-Martins (P)

Assistance Publique - Hôpitaux de Paris (AP-HP), Laboratoire d'Immunologie, Hôpital Européen Georges-Pompidou, Paris, France.

Pauline Bordereau (P)

Assistance Publique - Hôpitaux de Paris (AP-HP), Laboratoire d'Immunologie, Hôpital Européen Georges-Pompidou, Paris, France.

Aurélia Gruber (A)

Assistance Publique - Hôpitaux de Paris (AP-HP), Laboratoire d'Immunologie, Hôpital Européen Georges-Pompidou, Paris, France.

Magali Devriese (M)

Assistance Publique - Hôpitaux de Paris (AP-HP), Laboratoire d'Immunologie, Hôpital Européen Georges-Pompidou, Paris, France.

Loïc de Pontual (L)

Pediatrics Department, Jean Verdier Hospital, Assistance Publique des Hôpitaux de Paris, Paris 13 University, Bondy, France.

Muhamed-Kheir Taha (MK)

Invasive Bacterial Infection and National Reference Center for Meningococci, Pasteur Institut, Paris, France.

Claire Fieschi (C)

Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Inserm U1126, Centre Hayem, Hôpital Saint-Louis, Paris, France.

Capucine Picard (C)

Paris University, INSERM UMR1163, Imagine Institute, Paris, France.
Study Center for Primary Immunodeficiencies (AP-HP), Hôpital Necker-Enfants maladies Hospital, Paris, France.

Véronique Frémeaux-Bacchi (V)

Assistance Publique - Hôpitaux de Paris (AP-HP), Laboratoire d'Immunologie, Hôpital Européen Georges-Pompidou, Paris, France.
Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université Paris Descartes, Complement and Diseases Team, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH